High Research S.r.l.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
High Research S.r.l. - overview
Established
2001
Location
Milan, -, Italy
Primary Industry
Healthcare
About
High Research S. r. l. , based in Milan, Italy, specializes in providing comprehensive contract research services to enhance clinical research and product launches, primarily targeting the biopharmaceutical sector.
Founded in 2001 in Milan, Italy, High Research S. r. l. operates as a Contract Research Organization (CRO), focusing on clinical research and product launches.
In September 2021, it became a fully owned subsidiary of Evidenze Group Europe SL. The acquisition aims to bolster Evidenze's global footprint and enhance its services in Italy and Spain. No information is available about the founder's previous ventures. High Research S.
r. l. offers a suite of services as a Full Value CRO, including study start-up services, clinical operations management, advanced data management, medical writing, and pharmacovigilance. They cater to various therapeutic areas, notably oncology, and primarily serve biopharmaceutical companies, including small to medium-sized firms, ensuring compliance with regulatory requirements while optimizing clinical trial processes.
In 2023, High Research S. r. l. generated a revenue of USD 2,092,338.
30, with an EBITDA of USD 516,301. 20. Their revenue model is based on project-based fees from B2B contracts, providing comprehensive solutions for managing clinical trials and regulatory submissions. The recent acquisition by Evidenze Group Europe SL is set to support High Research S.
r. l. in expanding its service offerings in Italy and Spain while increasing its global presence. The firm is strategizing to introduce new products in the near future, although specific launch dates are not provided.
Funding from the acquisition will facilitate these initiatives, allowing High Research to enhance its operational capabilities and market reach.
Current Investors
Evidenze Group Europe SL
Primary Industry
Healthcare
Sub Industries
Education & Training Services, Healthcare, Pharmaceutical Research & Development
Website
www.highresearch.it
Verticals
HealthTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
High Research S.r.l. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | High Research S.r.l. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.